Research led by Shift Health, with Alzheimer Europe and the University of Cologne highlights opportunities to make Alzheimer’s detection and diagnosis more person-centred. Published in BMC Health Services Research, the study calls for pathways reflecting people’s needs as biomarkers and AI reshape diagnosis.
A new report, Catalyzing Ontario’s Life Sciences Economy, released by Life Sciences Ontario and Shift Health, calls for targeted action to address the shortage of risk capital available to early-stage life sciences companies in the province. The report identifies seed-stage investment as the critical missing link to securing Ontario’s global leadership in life sciences.
Winners of this award prioritize employee needs, equip employees with tools and resources for success and foster a positive culture of shared purpose.
This peer-reviewed paper presents solutions to alleviate health system capacity constraints for retinal care.
The report is informed by the findings from a national survey of life sciences organizations and focus groups with diverse individuals working in the sector.
Winners of this award prioritize employee needs, equip employees with tools and resources for success and foster a positive culture of shared purpose.
Pre-Exposure Prophylaxis (PrEP) is emerging as a valuable approach to protect at-risk individuals against infectious diseases. To capture opportunities in this expanding area, innovators will need to account for unique clinical, commercial and access considerations.
Black History Month is a time to listen to the voices of our Black colleagues who, through their exceptional leadership, enable us to continue breaking barriers in healthcare and STEM.
Shift Health is honoured to have been named an I.D.E.A.L. Bioscience EmployerTM by BioTalent Canada.
The I.D.E.A.L Bioscience Employer Recognition program recognizes organizations in